GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » EBITDA Margin %

THC Therapeutics (THC Therapeutics) EBITDA Margin %

: 0.00% (As of Jul. 2023)
View and export this data going back to 2007. Start your Free Trial

EBITDA Margin % is calculated as EBITDA divided by its Revenue. THC Therapeutics's EBITDA for the three months ended in Jul. 2023 was $-0.01 Mil. THC Therapeutics's Revenue for the three months ended in Jul. 2023 was $0.00 Mil. Therefore, THC Therapeutics's EBITDA margin for the quarter that ended in Jul. 2023 was 0.00%.


THC Therapeutics EBITDA Margin % Historical Data

The historical data trend for THC Therapeutics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
EBITDA Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

THC Therapeutics Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
EBITDA Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


THC Therapeutics EBITDA Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's EBITDA Margin % falls into.



THC Therapeutics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

THC Therapeutics's EBITDA Margin % for the fiscal year that ended in Jul. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=-0.306/0
= %

THC Therapeutics's EBITDA Margin % for the quarter that ended in Jul. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jul. 2023 )/Revenue (Q: Jul. 2023 )
=-0.012/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


THC Therapeutics  (OTCPK:THCT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


THC Therapeutics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


THC Therapeutics (THC Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135
Website
THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.
Executives
Hiro Tanaka director, officer: Vice President 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R director, officer: Chair of the Board 119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann director, 10 percent owner, officer: CEO, CFO 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho director, officer: CEO 701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX